Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/1/2020
SIETES contiene 92882 citas

 
 
 1 a 9 de 9 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Parker L, Fabbri A, Grundy Q, Mintzes B, Bero L. “Asset exchange”—interactions between patient groups and pharmaceutical industry: Australian qualitative study. BMJ 2019;367:12 de diciembre. [Ref.ID 103224]
2. Cita con resumen
Habibi R, Lexchin J, Mintzes B, Holbrook A. Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?. Br J Clin Pharmacol 2017;83:2549-56. [Ref.ID 102116]
3.Tiene citas relacionadas Cita con resumen
Mintzes B. When drugs don’t make it to market. BMJ 2015;350:h2852. [Ref.ID 99188]
4. Cita con resumen
Mintzes B, Lexchin J, Sutherland JM, Beaulieu MD, Wilkes MS, Durrieu G, Reynolds E. Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United States. J Gen Intern Med 2013;28:1368-75. [Ref.ID 95199]
5.Tiene citas relacionadas
Mintzes B. Direct to consumer advertising of prescription drugs. BMJ 2008;337:526-7. [Ref.ID 84015]
7.Enlace a cita original Cita con resumen
Mintzes B. Disease mongering in drug promotion. do governments have a regulatory role?. PLOS Medicine 2006;3:198. [Ref.ID 77490]
8.
Mansfield PR, Mintzes B, Richards D, Toop L. Direct to consumer advertising. BMJ 2004;330:5-6. [Ref.ID 72400]
9.Tiene citas relacionadas
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, Evans RG, Pan R, Marion SA. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. BMJ 2002;324:278-9. [Ref.ID 60249]
Seleccionar todas
 
 1 a 9 de 9